London, Ontario company selling ATLAS, an AI-powered lung-ultrasound diagnostic platform that runs offline on mobile devices, with FDA 510(k) clearance for its B-line detection model.
Canadian innovation builds a brighter tomorrow.
London, Ontario company selling ATLAS, an AI-powered lung-ultrasound diagnostic platform that runs offline on mobile devices, with FDA 510(k) clearance for its B-line detection model.
Federal corporation Deep Breathe Inc. (Juri ID 1224848-4), status Active, registered office in London, Ontario, incorporated 2020-08-06. ised-isde.canada.ca
Address is 45 King Street, Suite 300, London, ON, per its own site. deepbreathe.ai
Has FDA 510(k) clearance for its B-line detection model (secured, announced Oct. 15, 2025) and is pursuing further regulatory approvals for the broader ATLAS platform. deepbreathe.ai
Received up to $500,000 from the Ontario Life Sciences Innovation Fund, announced June 19, 2025. news.westernu.ca
Selected for the NATO DIANA 2026 Challenge Programme, announced Dec. 16, 2025. einpresswire.com
Products Deep Breathe publishes on its own site. Each card links to the page it was taken from.
AI lung-ultrasound diagnostics
Company describes an AI Tactical Assessment System with modules for trauma and pneumothorax detection, automating detection of life-threatening conditions with ultrasound at the point of care, running fully offline on iOS and Android and trained on 172 million ultrasound frames.
Learn moreGovernment support actually received. Unpublished amounts are left out.
Ontario Life Sciences Innovation Fund (LSIF)
Funding for Canadian Innovators and Accelerators of DIANA (FCIA-DIANA), National Defence
Regional Artificial Intelligence Initiative (RAII), Federal Economic Development Agency for Southern Ontario
Deep Breathe was selected to participate in NATO's DIANA 2026 Challenge Programme.
Deep Breathe announced FDA 510(k) clearance for its B-line detection model within the ATLAS lung-ultrasound platform.
Deep Breathe was awarded up to $500,000 from the Ontario Life Sciences Innovation Fund to expand its AI-powered lung ultrasound diagnostics, building on its archive of annotated lung ultrasound images.
Sourced from the company's own pages or announcements.
Rob Arntfield
Chief Executive Officer and Founder
Blake VanBerlo
Chief Technical Officer
Ross Prager
Chief Medical Officer
Terms the company uses about its own work.
Other companies in AI.
Discover companies, track funding, explore career opportunities and stay informed about Canada’s growing tech ecosystem.
